Posted January 29, 2002
Mixed News for RTP Companies: SciQuest Shows Loss; Pozen Gets Good News; Inspire Cuts Budget
RESEARCH TRIANGLE PARK —SciQuest CEO remains bullish despite $82.8 million loss for 2001; Pozen's migraine headache drug not a carcinogenic; Inspire to tighten focus but says it won't cut jobs....Copyright 2013 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Please log in to view WRALTechWire Insider content
Please Log In to add a comment.